Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1978
Macromolecular shape and surface maps by solvent exclusion
J Greer, B L Bush
Journal of Computer-Aided Molecular Design
|
October 1, 1993
Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA
B L Bush, R B Nachbar
Methods in Enzymology
|
January 1, 1994
Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis
J C Culberson, B L Bush, V V Sardana
Journal of Computer-Aided Molecular Design
|
June 1, 1994
Extending the trend vector: the trend matrix and sample-based partial least squares
R P Sheridan, R B Nachbar, B L Bush
Biophysical Journal
|
March 1, 1997
The statistical-thermodynamic basis for computation of binding affinities: a critical review
M K Gilson, J A Given, B L Bush, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
Modeling the mechanism of peptide cleavage by thermolysin
D G Hangauer, P Gund, J D Andose, et al.
Human Immunology
|
August 1, 1993
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix protein
S Y Sauma, M C Gammon, M A Bednarek, et al.
Journal of Medicinal Chemistry
|
March 6, 1992
Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors
S E de Laszlo, B L Bush, J J Doyle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences
I I Singer, D W Kawka, J A DeMartino, et al.
Biochemistry
|
March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site
V V Sardana, A J Schlabach, P Graham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1978
Macromolecular shape and surface maps by solvent exclusion
J Greer, B L Bush
Journal of Computer-Aided Molecular Design
|
October 1, 1993
Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA
B L Bush, R B Nachbar
Methods in Enzymology
|
January 1, 1994
Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis
J C Culberson, B L Bush, V V Sardana
Journal of Computer-Aided Molecular Design
|
June 1, 1994
Extending the trend vector: the trend matrix and sample-based partial least squares
R P Sheridan, R B Nachbar, B L Bush
Biophysical Journal
|
March 1, 1997
The statistical-thermodynamic basis for computation of binding affinities: a critical review
M K Gilson, J A Given, B L Bush, et al.
Annals of the New York Academy of Sciences
|
January 1, 1985
Modeling the mechanism of peptide cleavage by thermolysin
D G Hangauer, P Gund, J D Andose, et al.
Human Immunology
|
August 1, 1993
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix protein
S Y Sauma, M C Gammon, M A Bednarek, et al.
Journal of Medicinal Chemistry
|
March 6, 1992
Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors
S E de Laszlo, B L Bush, J J Doyle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1993
Optimal humanization of 1B4, an anti-CD18 murine monoclonal antibody, is achieved by correct choice of human V-region framework sequences
I I Singer, D W Kawka, J A DeMartino, et al.
Biochemistry
|
March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site
V V Sardana, A J Schlabach, P Graham, et al.
Page
of 2